Latest news

• FDA approves first cholera vaccine in US

  FDA approves first cholera vaccine in US. PaxVax’ s oral vaccine Vaxchora will be launched by September. ... It is a live attenuated vaccine, incorporating a weakened strain of the Vibrio cholera bacteria that causes the disease.

• Sanofi enters vaccines partnership with Sutro

  Sanofi Pasteur's vaccines currently cover 20 infectious diseases, including tuberculosis, cholera, influenza and hepatitis, and it is currently investigating a product to protect against the dengue virus.

• Moving with the times: pharma market research and digital

  Big data is already being harnessed to track disease. “ By following Twitter conversations alone, it was possible to predict a cholera epidemic two weeks before it would have shown up normally.

• J&J to buy remaining shares in Crucell

  as hepatitis, influenza, typhoid and cholera.

• Kicking the habit

  Preliminary data from a phase I trial of the vaccine, which comprises a nicotine derivative conjugated to a recombinant cholera toxin B, indicated that self-reported quit rates were considerably greater